-FirstPost.com With the hype of his Madison Square Garden show overshadowing everything else, Prime Minister Narendra Modi's US visit was dubbed as a great bilateral victory for India. As the popular consensus went, Modi wowed both the Indian Americans and American politicians and even managed to get a joint op-ed article with President Barack Obama in the Washington Post stressing the importance of the partnership between the two countries. Was it really...
More »SEARCH RESULT
Has PM Modi bowed to US pressure on patent laws? -Rema Nagarajan
-The Times of India A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws. Several health policy experts and activists have issued statements urging India not to give in to US...
More »'Blacklisted' Donor Agency Funds Gujarat Government Projects -Sreenivasan Jain
-NDTV After the Intelligence Bureau controversially concluded that Greenpeace India is "a threat to national economic security", the government asked for tighter controls on moving funds from abroad into the NGO's accounts. NDTV has learnt that one of the blacklisted foreign donors, the U.S.-based Climate Works Foundation, has helped fund projects run by the government in Gujarat, the home state of Prime Minister Narendra Modi. The Intelligence Bureau said in its report...
More »Friction over drug patents
-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...
More »India must call the US' bluff on patents-Arvind Panagariya
-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...
More »